We are live on ! Find out more
GF

Gabelli Funds Portfolio holdings

AUM $14.8B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+9.25%
1 Year Est. Return
+32.24%
3 Year Est. Return
+88.06%
5 Year Est. Return
+130.29%
10 Year Est. Return
+486.58%
AUM
$14.1B
AUM Growth
+$963M
Cap. Flow
-$36.3M
Cap. Flow %
-0.26%
Top 10 Hldgs %
12.86%
Holding
1,287
New
192
Increased
280
Reduced
411
Closed
65

Top Buys

Rank Stock Value
1
SWTX
SpringWorks Therapeutics
SWTX
+$28.6M
2
BPMC
Blueprint Medicines
BPMC
+$21.9M
3
SKX
Skechers
SKX
+$16.9M
4
FARO
Faro Technologies
FARO
+$14M
5
DNB
Dun & Bradstreet
DNB
+$13M

Top Sells

Rank Stock Value
1
ITCI
Intra-Cellular Therapies Inc.
ITCI
+$43M
2
BECN
Beacon Roofing Supply, Inc.
BECN
+$20.6M
3
DFS
Discover Financial Services
DFS
+$18M
4
FNA
Paragon 28, Inc.
FNA
+$16.8M
5
NEM icon
Newmont
NEM
+$16.2M

Sector Composition

Rank Sector Weight
1 Industrials 20.94%
2 Financials 12.8%
3 Communication Services 10.31%
4 Technology 10.08%
5 Utilities 9.78%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HAIN icon
1126
Hain Celestial
HAIN
$47.8M
$130K ﹤0.01%
85,500
-91,500
-52% -$214K
CVAC
1127
DELISTED
CureVac
CVAC
$130K ﹤0.01%
+23,850
New +$94.6K
WOOF icon
1128
Petco
WOOF
$745M
$127K ﹤0.01%
45,000
– –
PACB icon
1129
Pacific Biosciences
PACB
$422M
$124K ﹤0.01%
100,000
– –
FTRE icon
1130
Fortrea Holdings
FTRE
$1.85B
$121K ﹤0.01%
24,500
-25,285
-51% -$136K
CAEP
1131
DELISTED
Cantor Equity Partners III
CAEP
$118K ﹤0.01%
+11,200
New +$118K
OCSAW
1132
Oculis Holding AG Warrants
OCSAW
$208M
$117K ﹤0.01%
13,670
– –
FIP icon
1133
FTAI Infrastructure
FIP
$500M
$111K ﹤0.01%
18,000
– –
WVVI icon
1134
Willamette Valley Vineyards
WVVI
$13.5M
$111K ﹤0.01%
20,000
– –
LFCR icon
1135
Lifecore Biomedical
LFCR
$162M
$110K ﹤0.01%
13,500
– –
PBI icon
1136
Pitney Bowes
PBI
$2.42B
$109K ﹤0.01%
10,000
– –
ENIC icon
1137
Enel Chile
ENIC
$5.96B
$102K ﹤0.01%
28,000
– –
JVSAR
1138
DELISTED
JV SPAC Acquisition Corp. Right
JVSAR
$102K ﹤0.01%
116,700
+37,200
+47% +$15.4K
BBGI icon
1139
Beasley Broadcasting Group
BBGI
$37.1M
$98.4K ﹤0.01%
23,700
-300
-1% -$1.52K
AVD icon
1140
American Vanguard Corp
AVD
$73.5M
$98K ﹤0.01%
25,000
– –
VATE icon
1141
INNOVATE Corp
VATE
$114M
$97.8K ﹤0.01%
19,000
+500
+3% +$2.99K
VALE icon
1142
Vale
VALE
$62.9B
$97.1K ﹤0.01%
10,000
– –
DDD icon
1143
3D Systems Corp
DDD
$420M
$95.5K ﹤0.01%
62,037
– –
BARK icon
1144
BARK
BARK
$74.8M
$88K ﹤0.01%
5,000
+2,500
+100% +$57.4K
RDI icon
1145
Reading International Class A
RDI
$32.9M
$81.1K ﹤0.01%
60,500
+3,000
+5% +$3.99K
JACS.RT
1146
Jackson Acquisition Co II Rights
JACS.RT
$78.1K ﹤0.01%
278,880
+228,230
+451% +$56.1K
CFFN icon
1147
Capitol Federal Financial
CFFN
$1.08B
$75K ﹤0.01%
12,300
– –
CIFR icon
1148
Cipher Digital
CIFR
$9.47B
$71.7K ﹤0.01%
15,000
– –
FLNC icon
1149
Fluence Energy
FLNC
$1.78B
$67.1K ﹤0.01%
10,000
– –
ARAY icon
1150
Accuray
ARAY
$28.4M
$61.6K ﹤0.01%
45,000
– –
44 45
46
47 48

Similar funds

FCAS
First Command Advisory Services Fort Worth, Texas $14.8B AUM 18.11% 1-Year Est. Return
BGC
Beutel, Goodman & Co Toronto, Ontario, Canada $14.8B AUM 15.12% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
CCM
Cantillon Capital Management New York $15.1B AUM 23.54% 1-Year Est. Return
AT
AMF Tjänstepension Stockholm, Sweden $15.1B AUM 30.1% 1-Year Est. Return
IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $15.1B AUM 26.53% 1-Year Est. Return

Gabelli Funds's Q2 2025 Portfolio in Review

As of Q2 2025, Gabelli Funds held 1,287 positions worth $14.1B, up 7.3% from $13.1B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Gabelli Funds's Q2 2025 filing shows 192 new, 280 increased, 411 reduced and 65 closed positions. Its largest new stake was Blueprint Medicines: 211,169 shares worth $27.1M. The largest sale was Intra-Cellular Therapies Inc., an estimated $43M.

By sector, the portfolio is most concentrated in Industrials at 21% of assets, up from 21% a quarter earlier, followed by Financials and Communication Services.

  • Gabelli Funds's largest Q2 2025 buy was Blueprint Medicines: 211,169 shares worth $27.1M.
  • Gabelli Funds added most to SpringWorks Therapeutics in Q2 2025, an estimated $28.6M increase.
  • Gabelli Funds's biggest Q2 2025 reduction was Newmont, cutting an estimated $16.2M.
  • Gabelli Funds fully exited Intra-Cellular Therapies Inc. in Q2 2025, selling an estimated $43M.
  • Gabelli Funds's ten largest holdings make up 13% of its $14.1B portfolio in Q2 2025.
  • Gabelli Funds opened 192 new positions and closed 65 in Q2 2025.
  • Gabelli Funds's portfolio value rose 7.3% quarter-over-quarter to $14.1B.

Based on Gabelli Funds's 13F filing for Q2 2025, filed 13 Aug 2025.